Sponsor or institution
Clinical trials and research at Shanghai Minwei Biotechnology Co., Ltd
As of November 12, 2026, Find a Trial lists 6 clinical trials run by Shanghai Minwei Biotechnology Co., Ltd that are recruiting, at sites in 2 countries (most in China (4), Australia (2)). By phase: Phase 1 (4), Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 2Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| MWX401 Injection in healthy adults and people with mild hypertension | Phase 1 | Nanjing, Jiangsu | Recruiting | Sep 4, 2026 |
| MWX203: a medicine for mixed dyslipidemia given alone or with Inclisiran | Phase 2 | Beijing, Beijing Municipality | Recruiting | Sep 4, 2026 |
| MWN105 injection in overweight or obese adults you may join | Phase 1 | Kunming, Yunnan | Recruiting | Sep 4, 2026 |
| MWN109 tablets in adults with type 2 diabetes mellitus | Phase 2 | Beijing, Beijing Municipality | Recruiting | Sep 3, 2026 |
| Testing MWN109 tablets in healthy adults | Phase 1 | Adelaide, South Australia and 1 other locations | Recruiting | Apr 22, 2025 |
| Evaluating MWN109 Injection in Healthy Volunteers | Phase 1 | Melbourne, Victoria | Recruiting | Mar 5, 2025 |
All recruiting trials (6)
-
MWX401 Injection in healthy adults and people with mild hypertension
This early Phase 1 study tests a single subcutaneous dose of MWX401 to see if it's safe and tolerable in healthy Chinese adults and in adults with mild high blood pressure.
-
MWX203: a medicine for mixed dyslipidemia given alone or with Inclisiran
This phase 2 study tests MWX203 alone or with Inclisiran in adults with mixed dyslipidemia who don’t reach lipid goals on statins.
-
MWN105 injection in overweight or obese adults you may join
This early-phase trial tests whether MWN105 is safe and tolerable in overweight or obese adults in China, using a placebo comparison.
-
MWN109 tablets in adults with type 2 diabetes mellitus
A phase 2 trial tests MWN109 tablets versus placebo (and against active control semaglutide) to see if the medicine helps adults with type 2 diabetes lower their blood sugar.
-
Testing MWN109 tablets in healthy adults
This trial will test MWN109 tablets versus placebo in healthy adults (including people with overweight or obesity) to see if the drug is safe, how the body handles it, and whether it triggers immune responses.
-
Evaluating MWN109 Injection in Healthy Volunteers
This study is testing the safety of a new injection called MWN109 in healthy volunteers to see how well they tolerate it compared to a placebo.
Quick answers
How many clinical trials run by Shanghai Minwei Biotechnology Co., Ltd are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (4 trials), Australia (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 4, Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.